Table 1.
Distribution of the studied cases according to demographic, clinical observation data, and the medication received (n = 40)
| Sex | |
| Male | 21 (52.5% |
| Female | 19 (47.5%) |
| Age (months) | |
| Min.–max. | 1.20–58.0 |
| Mean ± SD. | 15.48 ± 18.43 |
| SED | 2.91 |
| Weight(kg) | |
| Min.–max. | 3.5–20.0 |
| Mean ± SD. | 8.6 ± 4.86 |
| SED | 0.77 |
| Weight (Z score) | |
| Min.–max. | − 4.08–1.1 |
| Mean ± SD. | − 1.19 ± 1.45 |
| SED | 0.23 |
| Height(cm) | |
| Min.–max. | 49.00–112.00 |
| Mean ± SD. | 71.20 ± 17.90 |
| SED | 2.83 |
| Height (Z score) | |
| Min.–max. | − 5.18–2.22 |
| Mean ± SD. | − 1.16 ± 1.59 |
| SED | 0.25 |
| PIM2 | |
| Min.–max. | 7.00–95.00 |
| Mean ± SD. | 33.86 ± 23.16 |
| SED | 3.66 |
| MV (days) | |
| Min.–max. | 0.00–18.00 |
| Mean ± SD. | 5.35 ± 4.24 |
| SED | 0.67 |
| LOS (days) | |
| Min.–max. | 4.00–45.00 |
| Mean ± SD. | 15.48 ± 10.90 |
| SED | 1.72 |
| PELOD2 A | |
| Min.–max. | 2.00–15.00 |
| Mean ± SD. | 7.55 ± 2.79 |
| SED | 0.44 |
| PELOD2 B | |
| Min.–max. | 0.00–11.00 |
| Mean ± SD. | 4.80 ± 2.29 |
| SED | 0.36 |
| PELOD2 C | |
| Min.–max. | 0.00–7.00 |
| Mean ± SD. | 2.40 ± 1.85 |
| SED | 0.29 |
| Reversal of shock (in days) | |
| Min.–max. | 1.00–20.00 |
| Mean ± SD. | 5.23 ± 4.05 |
| SED | 0.64 |
| Medications received during their PICU stay | |
| Glucocorticoids | 22 (55%) |
| Furosemide | 10 (25%) |
| Phenobarbitone | 4 (10%) |
| Phenytoin | 9 (22.5%) |
| Heparin | 5 (12.5%) |
| Inotrope | |
| Single inotrope | 22 (55%) |
| Two inotropes | 11 (27.5%) |
| Three inotropes | 7 (17.5%) |
LOS length of stay, MV mechanical ventilation, PELOD pediatric logistic organ dysfunction, PIM2 pediatric index of mortality 2, A on admission, B on shock reversal, C five days after shock reversal, SED standard error of the mean